February 16, 2024 10:39 AM EST
News Briefing

XO­MA to buy Kin­nate; A pain biotech’s small IPO

Kyle LaHucik

Senior Reporter

Lei Lei Wu

News Reporter

Ayisha Sharma

News Reporter

Plus, news about Blue­print Med­i­cines, So­sei Group and Pox­el:

XO­MA to buy Kin­nate Bio­phar­ma: The biotech roy­al­ty ag­gre­ga­tor said it would …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times